Table of Contents Author Guidelines Submit a Manuscript
Stroke Research and Treatment
Volume 2015, Article ID 768401, 4 pages
http://dx.doi.org/10.1155/2015/768401
Clinical Study

Copeptin: Limited Usefulness in Early Stroke Differentiation?

1Division of Emergency Medicine, Department of Cardiology, Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany
2B.R.A.H.M.S GmbH, Thermo Scientific Clinical Diagnostics, 16761 Hennigsdorf, Germany
3Department of Neurology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany
4Center for Stroke Research Berlin, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany
5German Center for Neurodegenerative Diseases (DZNE), Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany
6German Centre for Cardiovascular Research (DZHK), Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany

Received 18 March 2015; Revised 27 May 2015; Accepted 28 May 2015

Academic Editor: Scott Kasner

Copyright © 2015 Johannes von Recum et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Emberson, K. R. Lees, P. Lyden et al., “Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials,” The Lancet, vol. 384, no. 9958, pp. 1929–1935, 2014. View at Publisher · View at Google Scholar
  2. O. A. Berkhemer, P. S. S. Fransen, D. Beumer et al., “A randomized trial of intraarterial treatment for acute ischemic stroke,” The New England Journal of Medicine, vol. 372, no. 1, pp. 11–20, 2015. View at Publisher · View at Google Scholar
  3. M. Goyal, A. M. Demchuk, B. K. Menon et al., “Randomized assessment of rapid endovascular treatment of ischemic stroke,” The New England Journal of Medicine, vol. 372, pp. 1019–1030, 2015. View at Publisher · View at Google Scholar
  4. B. C. Campbell, P. J. Mitchell, T. J. Kleinig et al., “Endovascular therapy for ischemic stroke with perfusion-imaging selection,” The New England Journal of Medicine, vol. 372, pp. 1009–1018, 2015. View at Publisher · View at Google Scholar
  5. M. Katan, F. Fluri, N. G. Morgenthaler et al., “Copeptin: a novel, independent prognostic marker in patients with ischemic stroke,” Annals of Neurology, vol. 66, no. 6, pp. 799–808, 2009. View at Publisher · View at Google Scholar
  6. G. M. De Marchis, M. Katan, A. Weck et al., “Copeptin and risk stratification in patients with ischemic stroke and transient ischemic attack: the CoRisk Study,” International Journal of Stroke, vol. 8, no. 3, pp. 214–218, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. G. L. Robertson, “Antidiuretic hormone: normal and disordered function,” Endocrinology and Metabolism Clinics of North America, vol. 30, no. 3, pp. 671–694, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. M. W. Dünser, V. Wenzel, A. J. Mayr, and W. R. Hasibeder, “Management of vasodilatory shock: defining the role of arginine vasopressin,” Drugs, vol. 63, no. 3, pp. 237–256, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Struck, N. G. Morgenthaler, and A. Bergmann, “Copeptin, a stable peptide derived from the vasopressin precursor, is elevated in serum of sepsis patients,” Peptides, vol. 26, no. 12, pp. 2500–2504, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. B. Müller, N. Morgenthaler, D. Stolz et al., “Circulating levels of copeptin, a novel biomarker, in lower respiratory tract infections,” European Journal of Clinical Investigation, vol. 37, no. 2, pp. 145–152, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Mockel, “Copeptin adds to high-sensitivity troponin T in rapid rule out of acute myocardial infarction,” Clinical Chemistry, vol. 58, no. 1, pp. 306-307, 309–311, 2012. View at Google Scholar
  12. “The World Health Organization MONICA project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. WHO MONICA Project Principal Investigators,” Journal of Clinical Epidemiology, vol. 41, no. 2, pp. 105–114, 1988.
  13. H. Ay, W. J. Koroshetz, T. Benner et al., “Transient ischemic attack with infarction: a unique syndrome?” Annals of Neurology, vol. 57, no. 5, pp. 679–686, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Keller, S. Tzikas, T. Zeller et al., “Copeptin improves early diagnosis of acute myocardial infarction,” Journal of the American College of Cardiology, vol. 55, no. 19, pp. 2096–2106, 2096. View at Publisher · View at Google Scholar
  15. T. Reichlin, W. Hochholzer, C. Stelzig et al., “Incremental value of copeptin for rapid rule out of acute myocardial infarction,” Journal of the American College of Cardiology, vol. 54, no. 1, pp. 60–68, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. S. A. Urwyler, P. Schuetz, F. Fluri et al., “Prognostic value of copeptin: one-year outcome in patients with acute stroke,” Stroke, vol. 41, no. 7, pp. 1564–1567, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Zweifel, M. Katan, P. Schuetz et al., “Copeptin is associated with mortality and outcome in patients with acute intracerebral hemorrhage,” BMC Neurology, vol. 10, article 34, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. G. M. de Marchis, M. Katan, A. Weck et al., “Copeptin adds prognostic information after ischemic stroke: results from the CoRisk study,” Neurology, vol. 80, no. 14, pp. 1278–1286, 2013. View at Publisher · View at Google Scholar · View at Scopus